Gilead(GILD) - 2025 FY - Earnings Call Transcript

Gilead Sciences (NasdaqGS:GILD) FY 2025 Conference December 02, 2025 11:15 AM ET Company ParticipantsNone - Company RepresentativeConference Call ParticipantsNone - AnalystNoneUsed in about 45% of HIV prevention patients today. It's a once-daily pill with two medicines. The daily orals work really well. The challenge is that people that don't have HIV do not take the pills on a daily basis, so you don't get the benefit that you would get if people stayed on the pills every day. It's really challenging. The ...